These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31931398)

  • 1. Retrospective Analysis of Low-Molecular-Weight Heparin and Unfractionated Heparin in Pediatric Trauma Patients: A Comparative Analysis.
    Culbert MH; Hamidi M; Zeeshan M; Hanna K; Romero A; Joseph B; O'Keeffe T
    J Surg Res; 2020 May; 249():121-129. PubMed ID: 31931398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unfractionated heparin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in trauma.
    Jacobs BN; Cain-Nielsen AH; Jakubus JL; Mikhail JN; Fath JJ; Regenbogen SE; Hemmila MR
    J Trauma Acute Care Surg; 2017 Jul; 83(1):151-158. PubMed ID: 28426561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the impact of culture on venous thromboembolism prevention in trauma patients: A Southwestern Surgical Congress Multicenter trial.
    Regner JL; Shaver CN;
    Am J Surg; 2019 Jun; 217(6):1030-1036. PubMed ID: 30503515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The survival benefit of low molecular weight heparin over unfractionated heparin in pediatric trauma patients.
    Khurrum M; Asmar S; Henry M; Ditillo M; Chehab M; Tang A; Bible L; Gries L; Joseph B
    J Pediatr Surg; 2021 Mar; 56(3):494-499. PubMed ID: 32883505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A tale of two centers: Is low-molecular-weight heparin really superior for prevention of posttraumatic venous thromboembolism?
    Checchi KD; Costantini TW; Badiee J; Berndtson AE; Calvo RY; Rooney AS; Wessels LE; Prieto JM; Sise CB; Sise MJ; Martin MJ; Bansal V
    J Trauma Acute Care Surg; 2021 Sep; 91(3):537-541. PubMed ID: 33901051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of unfractionated heparin versus low-molecular-weight heparin and fondaparinux for pharmacologic venous thromboembolic prophylaxis in critically ill patients with cancer.
    Van Matre ET; Reynolds PM; MacLaren R; Mueller SW; Wright GC; Moss M; Burnham EL; Ho PM; Vandivier RW; Kiser TH
    J Thromb Haemost; 2018 Dec; 16(12):2492-2500. PubMed ID: 30347498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enoxaparin may be associated with lower rates of mortality than unfractionated heparin in neurocritical and surgical patients.
    Samuel S; To C; Ling Y; Zhang K; Jiang X; Bernstam EV
    J Thromb Thrombolysis; 2023 Apr; 55(3):439-448. PubMed ID: 36624202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is low-molecular-weight heparin safe for venous thromboembolism prophylaxis in patients with traumatic brain injury? A Western Trauma Association multicenter study.
    Kwiatt ME; Patel MS; Ross SE; Lachant MT; MacNew HG; Ochsner MG; Norwood SH; Speier L; Kozar R; Gerber JA; Rowell S; Krishnakumar S; Livingston DH; Manis G; Haan JM
    J Trauma Acute Care Surg; 2012 Sep; 73(3):625-8. PubMed ID: 22929493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.
    Kanaan AO; Silva MA; Donovan JL; Roy T; Al-Homsi AS
    Clin Ther; 2007 Nov; 29(11):2395-405. PubMed ID: 18158080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effectiveness of low-molecular-weight heparin versus unfractionated heparin for thromboembolism prophylaxis for medical patients.
    Rothberg MB; Pekow PS; Lahti M; Lindenauer PK
    J Hosp Med; 2012; 7(6):457-63. PubMed ID: 22473716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low Molecular Weight Heparin Is Superior for Venous Thromboembolism Prophylaxis in High-Risk Geriatric Patients.
    Deusenberry CM; Bardsley C; Sharon M; Hobbs GR; Wilson AM; Bardes JM
    Am Surg; 2023 Dec; 89(12):5837-5841. PubMed ID: 37208855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-Molecular Weight Heparin is Superior to Unfractionated Heparin for Elderly Trauma Patients.
    Gaitanidis A; Breen KA; Christensen MA; Saillant NN; Kaafarani HMA; Velmahos GC; Mendoza AE
    J Surg Res; 2021 Dec; 268():432-439. PubMed ID: 34416415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of the effectiveness of low molecular weight heparin for venous thromboembolism prophylaxis in trauma patients.
    Gritsiouk Y; Hegsted DA; Schlesinger P; Gardiner SK; Gubler KD
    Am J Surg; 2014 May; 207(5):648-51; discussion 651-2. PubMed ID: 24560359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and Safety of Low Molecular Weight Heparin Versus Unfractionated Heparin for Prevention of Venous Thromboembolism in Trauma Patients: A Systematic Review and Meta-analysis.
    Tran A; Fernando SM; Carrier M; Siegal DM; Inaba K; Vogt K; Engels PT; English SW; Kanji S; Kyeremanteng K; Lampron J; Kim D; Rochwerg B
    Ann Surg; 2022 Jan; 275(1):19-28. PubMed ID: 34387202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
    Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
    Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower Mortality and Morbidity with Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis in Spine Trauma.
    Neifert SN; Chapman EK; Rothrock RJ; Gilligan J; Yuk F; McNeill IT; Rasouli JJ; Gal JS; Caridi JM
    Spine (Phila Pa 1976); 2020 Dec; 45(23):1613-1618. PubMed ID: 33156289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-molecular-weight heparin versus unfractionated heparin in pediatric traumatic brain injury.
    van Erp IA; Gaitanidis A; El Moheb M; Kaafarani HMA; Saillant N; Duhaime AC; Mendoza AE
    J Neurosurg Pediatr; 2021 Apr; 27(4):469-474. PubMed ID: 33578391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
    Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
    Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism chemoprophylaxis in geriatric trauma patients with isolated severe traumatic brain injury.
    Condon F; Grigorian A; Russell D; Demetriades D
    Eur J Trauma Emerg Surg; 2024 Feb; 50(1):197-203. PubMed ID: 37306760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological Thromboembolic Prophylaxis in Traumatic Brain Injuries: Low Molecular Weight Heparin Is Superior to Unfractionated Heparin.
    Benjamin E; Recinos G; Aiolfi A; Inaba K; Demetriades D
    Ann Surg; 2017 Sep; 266(3):463-469. PubMed ID: 28650361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.